Posttransplant lymphoproliferative disorder: Experience from a pediatric nephrology unit in North India
Pankaj Hari(Indian Council of Medical Research), Ramesh Kumar(Amrita Institute of Medical Sciences and Research Centre), Arvind Bagga(All India Institute of Medical Sciences), Swati Bhardwaj(All India Institute of Medical Sciences), Aditi Sinha
Cited by 3
Related Papers
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203